1Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy[J]. Am J Cardiol, 2003, 91(6A): 2D-8D.
2Trulock KM, Narayan SM, Piccini JP. Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation[J]. J Am Call Cardiol, 2014, 64(7): 710-721.
3Lip GY, Laroche C, Popescu MI, et al. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational research programme pilot survey on Atrial Fibrillation[J]. Eur J Heart Fail, 2015, 17(6): 570-582.
4Mountantonakis SE, Grau-Sepulveda MV, Bhatt DL, et al. Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure [J]. Circ Heart Fail, 2012, 5(2): 191-201.
5Khazanie P, Liang L, Quails LG, et al. Outcomes of medicare beneficiaries with heart failure and atrial fibrillation[J]. JACC Heart Fail, 2014, 2(1): 41-48.
6Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control[J]. J Am Coll Cardiol, 2011, 58(14): 1474-1481.
7Najib MQ, Vinales KL, Vittala SS, et al. Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation[J]. Echocardiography, 2012, 29(2): 140-146.
8Park JH, Shin SH, Lee MJ, et al. Clinical and echocardiographic factors affecting tricuspid regurgitation severity in the patients with lone atrial fibrillation[J]. J Cardiovasc Ultrasound, 2015, 23(3): 136-142.
9Redfield MM, Kay GN, Jenkins LS, et al. Tachycardia- related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation[J]. Mayo Clin Proc, 2000, 75(8): 790-795.
10Zimmermann AJ, Bossard M, Aeschbacher S, et al. Effects of sinus rhythm maintenance on left heart function after electrical cardioversion of atrial fibrillation: implications for tachycardia-induced cardiomyopathy [J]. Can J Cardiol, 2015, 31(1): 36-43.
